A phase II study of an investigational tetravalent influenza vaccine formulation combining MF59®: adjuvanted, pre-pandemic, A/H5N1 vaccine and trivalent seasonal influenza vaccine in healthy adults.
Hum Vaccin Immunother
; 10(1): 92-9, 2014.
Article
in En
| MEDLINE
| ID: mdl-24047817
Full text:
1
Collection:
01-internacional
Database:
MEDLINE
Main subject:
Influenza B virus
/
Polysorbates
/
Squalene
/
Influenza Vaccines
/
Adjuvants, Immunologic
/
Influenza A Virus, H1N1 Subtype
/
Influenza A Virus, H3N2 Subtype
/
Influenza A Virus, H5N1 Subtype
Type of study:
Clinical_trials
/
Observational_studies
Limits:
Adolescent
/
Adult
/
Female
/
Humans
/
Male
/
Middle aged
Language:
En
Journal:
Hum Vaccin Immunother
Year:
2014
Document type:
Article